pharma · Anemia · Anemia Associated With Chronic Kidney Disease · AKBA
Akebia Europe
Akebia Europe Limited
Akebia Europe clinical programs — 7 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Cambridge, USA
- Founded
- 2007
- Employees
- 271
- Programs
- 25
- Drugs
- 13
- Patents
- 28
Akebia Europe projects
7 ClinicalTrials.gov programs sponsored by Akebia Europe.
Akebia Europe has 7 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Epoetin alga (Epogen)/vadadustat
Akebia Europe Limited
Anemia Associated With Chronic Kidney Disease
1 trial -
Erythropoiesis-Stimulating Agent (ESA)
Akebia Europe Limited
Anemia of Chronic Kidney Disease
1 trial -
Ferric Citrate 1 GM Oral Tablet [AURYXIA]
Akebia Europe Limited
Anemia, Iron Deficiency
1 trial -
Vadadustat
Akebia Europe Limited
Anemia of Chronic Kidney Disease
3 trials -
Vadadustat
Akebia Europe Limited
Anemia
10 trials -
Vadadustat
Akebia Europe Limited
Anemia Associated With Chronic Kidney Disease (CKD)
1 trial -
Vadadustat 900mg
Akebia Europe Limited
Nonintubated Acute Respiratory Distress Syndrome (ARDS)
1 trial
Frequently asked questions
How many clinical projects does Akebia Europe have?
7 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.